Two more biotechnology products receive orphan drug designation

被引:0
|
作者
不详
机构
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
引用
收藏
页码:417 / 417
页数:1
相关论文
共 50 条
  • [1] Two more biotechnology products receive orphan drug designation
    不详
    [J]. BIOTECHNOLOGY LAW REPORT, 1999, 18 (05) : 407 - 408
  • [3] IS ORPHAN DESIGNATION A DRIVER OF ORPHAN DRUG PRICING?
    Degrassat-Theas, A.
    Paubel, P.
    de Curzon, Parent O.
    Berard, F.
    Poisson, N.
    Le Pen, C.
    Sinegre, M.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A302 - A302
  • [4] Orphan Drug Designation for Qutenza
    不详
    [J]. JOURNAL OF DRUGS IN DERMATOLOGY, 2009, 8 (08) : 777 - 777
  • [5] Evaluating the impact of the FDA's orphan drug designation on share prices of biotechnology companies
    Williamson, Joab
    Spicer, Alexander James
    [J]. DRUG DISCOVERY TODAY, 2020, 28 (12)
  • [6] RegeneRx receives Orphan Drug designation
    不详
    [J]. WOUNDS-A COMPENDIUM OF CLINICAL RESEARCH AND PRACTICE, 2004, 16 (07): : A22 - +
  • [7] Worldwide collaboration for orphan drug designation
    Mariz, Segundo
    Reese, James H.
    Westermark, Kerstin
    Greene, Lesley
    Goto, Takahiro
    Hoshino, Tatsuro
    Llinares-Garcia, Jordi
    Sepodes, Bruno
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2016, 15 (06) : 440 - 440
  • [8] Worldwide collaboration for orphan drug designation
    Segundo Mariz
    James H. Reese
    Kerstin Westermark
    Lesley Greene
    Takahiro Goto
    Tatsuro Hoshino
    Jordi Llinares-Garcia
    Bruno Sepodes
    [J]. Nature Reviews Drug Discovery, 2016, 15 : 440 - 441
  • [9] Orphan Drug Designation and PharmacogenomicsOptions and Opportunities
    Paul D. Maher
    Marlene Haffner
    [J]. BioDrugs, 2006, 20 : 71 - 79
  • [10] Orphan drug designation for NTZ expanded
    不详
    [J]. AIDS PATIENT CARE AND STDS, 1997, 11 (03) : 198 - 198